SLC22A12 and kidney disorder: Li et al. found that apigenin (IC50 = 0.64 μM/l) not only competitively inhibited URAT1 activity in vitro, but also (100 mg/kg) promoted uric acid excretion by inhibiting URAT1 activity in potassium oxonate-induced hyperuricemic nephropathy mice [43].